Top Healthcare Stocks
Healthcare stocks are narrowly lower with the NYSE Healthcare
Sector Index sliding about 0.2% although shares of healthcare
companies in the S&P 500 are now down over 0.5% as a group.
In company news, Vertex Pharmaceuticals Inc. (
) is 3.2% at $74.60 a share, just a few cents off its intra-day low
and the drug developer reporting interim Phase IIb test results for
its investigational kinase 3 inhibitor for rheumatoid arthritis,
saying the drug met its primary endpoints with statistically
significant responses but investors grew concerned about its
Overall, more than half - or 51.2% - of the patients in the
pooled VX-509 group experienced some adverse event, well above the
38.0% rate for patients who received placebos. Most of the observed
adverse events were characterized as mild to moderate.
In other sector news,
(+) WBMD, Buys back over 5.5 mln shares now owned by Carl Icahn
for $32.08 apiece, or $177.3 mln overall.
(-) VAR, Receives 510(
) clearance from the FDA for its knowledge-based treatment planning
software for radiation oncology.
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.